Canada: Abilify Impulse Control: The Costly Side-Effects Of One Of Canada's Most Prescribed Drugs

Last Updated: February 9 2017
Article by Paul Miller

Think back to the last time you had a prescription filled. Perhaps you're fortunate enough to have a drug plan. If not, you might have winced a bit as the total popped up on the cash register's display. What was the damage to your pocket book? Whatever the number, it's probably a lot lower than the $250,000 one Canadian man ended up paying for his Abilify prescription.

That $250,000 wasn't the cost of the prescription itself, of course; rather, it was how much he ended up gambling away as a result of the drug's impact on his ability to exercise impulse control. In this blog post, I explore the troubling potential side effects of one of Canada's most commonly prescribed drugs. The cost of these side effects – to your finances, your health, and your relationships – are ones no one should ever have to pay – especially without full knowledge of the risks.

What is Abilify?

Aripiprazole, often branded as Abilify, Abilify Maintena, or Aristada, is a second-generation, atypical anti-psychotic drug. Heralded as a breakthrough, this drug is known as a stabilizer because unlike first-generation anti-psychotics, it adjusts dopamine and serotonin levels in the brain rather than simply blocking chemical receptors.

In Canada, it was approved to treat schizophrenia and bipolar (Type I) in people 13 years of age or older. It is also frequently prescribed "off-label" to treat conditions such as Tourette's syndrome, irritability related to autism, anxiety disorders, ADHD, and general depression.

Like most legally approved pharmaceuticals, Abilify is considered generally safe but known to cause side effects in some people. These include, but are not limited to:

  • Nausea and/or vomiting;
  • Dizziness;
  • Blurred vision;
  • Headache;
  • Insomnia;
  • Restlessness (akathisia) or uncontrolled body movements (tardive dyskinesia);
  • Neuroleptic malignant syndrome (NMS);
  • High blood sugar (hyperglycemia) and diabetes;
  • Orthostatic hypotension (decreased blood pressure);
  • Low white blood cell count;
  • Seizures (convulsions); and
  • Strokes in the elderly

Impulse Control Issues

Although Abilify's makers have been forthcoming about the risk of these side effects, they were slow to divulge other serious potential side effects concerning impulse control. Medical case studies and patient reports revealed incidents of problem gambling, binge eating or compulsive eating, compulsive shopping and hypersexuality while users were taking Abilify. When some of these patients stopped taking the drug this behaviour ceased, strongly suggesting a link.

Moreover, research discovered that certain Abilify users – people with personal or familial histories of obsessive-compulsive disorder (OCD), alcohol and drug abuse, bipolar disorder, and other types of impulsive personalities or addictive behaviours – were particularly at risk of experiencing these side effects. Yet some people who had not previously experienced difficulties with impulse control were also affected.

Where Were The Warnings?

One of the most frustrating aspects of this story is evidence that Abilify's maker knowingly made "false or misleading" statements about the drug that slowed federal regulators from taking action to protect users sooner. Stricter labelling standards and information protocols in Europe meant doctors and patients were warned of these serious side effects in 2012 – three years before the US Food and Drug Administration and Health Canada took action. Probably as a result, Abilify is prescribed much less frequently in Europe than in North America.

Why the delay? Arguably, Abilify's makers knew that by advertising these risks there would be a cost to their bottom line that they sought to postpone paying as long as possible. Unfortunately, in the interim, some people taking Abilify were paying a huge cost of their own. In addition to the monetary losses from uncontrollable gambling, shopping or food and drug abuse, these victims engaged in behaviour which undoubtedly increased their risk of physical harm, ill health and strained relationships.

Seeking Justice

It is unconscionable that drug makers would knowingly expose these people to such risks without adequate warning. Preventing people from making an informed decision about their health care demands serious consequences. In addition to seeking compensation for physical, mental and economic damages, some victims are looking to ensure the drug's manufacturers faced punitive damages for their role.

In Canada, Abilify victims have come together to participate in a mass tort action. Unlike class action lawsuits, mass tort actions allow people who have suffered various degrees of injury (and therefore cannot be grouped into a single class of plaintiffs) to proceed with cases individually or collectively. This type of action, funded on a contingency basis, reduces the financial barriers to participation and provides flexibility to victims. They may seek to use awards structure established by others' cases as the basis for settlements or to pursue their own distinct claim.

In consultation with a medical professional, when deciding whether to take a drug known to cause potential side effects, a patient must weigh the benefits of the drug versus its risks. By withholding key information, Abilify's makers skewed the odds and made this decision more of a gamble than some people would be willing to take otherwise. They should be held accountable for their actions and the damage it has caused.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions